• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然药物单体的“特洛伊木马”递送策略:改善脑靶向性面临的挑战与局限

Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting.

作者信息

Lei Kelu, Zhou Lanyu, Dan Min, Yang Fei, Jian Tiantian, Xin Juan, Yu Zhigang, Wang Yue

机构信息

Department of Pharmacy, Ya'an People's Hospital-West China Ya'an Hospital, Sichuan University, Ya'an 625000, China.

State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.

出版信息

Pharmaceutics. 2025 Feb 20;17(3):280. doi: 10.3390/pharmaceutics17030280.

DOI:10.3390/pharmaceutics17030280
PMID:40142943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11945504/
Abstract

Central nervous system (CNS) diseases, such as brain tumors, Alzheimer's disease, and Parkinson's disease, significantly impact patients' quality of life and impose substantial economic burdens on society. The blood-brain barrier (BBB) limits the effective delivery of most therapeutic drugs, especially natural products, despite their potential therapeutic effects. The Trojan Horse strategy, using nanotechnology to disguise drugs as "cargo", enables them to bypass the BBB, enhancing targeting and therapeutic efficacy. This review explores the applications of natural products in the treatment of CNS diseases, discusses the challenges posed by the BBB, and analyzes the advantages and limitations of the Trojan Horse strategy. Despite the existing technical challenges, future research is expected to enhance the application of natural drugs in CNS treatment by integrating nanotechnology, improving delivery mechanisms, and optimizing targeting characteristics.

摘要

中枢神经系统(CNS)疾病,如脑肿瘤、阿尔茨海默病和帕金森病,严重影响患者的生活质量,并给社会带来巨大的经济负担。血脑屏障(BBB)限制了大多数治疗药物,尤其是天然产物的有效递送,尽管它们具有潜在的治疗效果。“特洛伊木马”策略利用纳米技术将药物伪装成“货物”,使其能够绕过血脑屏障,提高靶向性和治疗效果。本综述探讨了天然产物在中枢神经系统疾病治疗中的应用,讨论了血脑屏障带来的挑战,并分析了“特洛伊木马”策略的优缺点。尽管存在现有的技术挑战,但未来的研究有望通过整合纳米技术、改进递送机制和优化靶向特性,加强天然药物在中枢神经系统治疗中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d9/11945504/35da53e9cba7/pharmaceutics-17-00280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d9/11945504/9f1c1048d7d7/pharmaceutics-17-00280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d9/11945504/35da53e9cba7/pharmaceutics-17-00280-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d9/11945504/9f1c1048d7d7/pharmaceutics-17-00280-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23d9/11945504/35da53e9cba7/pharmaceutics-17-00280-g002.jpg

相似文献

1
Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting.天然药物单体的“特洛伊木马”递送策略:改善脑靶向性面临的挑战与局限
Pharmaceutics. 2025 Feb 20;17(3):280. doi: 10.3390/pharmaceutics17030280.
2
Development of Brain Permeable Drugs and Novel Strategies to Overcome the Brain Barriers for Treatment Purposes.用于治疗目的的脑渗透性药物的开发及克服血脑屏障的新策略。
Curr Pharm Des. 2025 Apr 21. doi: 10.2174/0113816128386983250410092649.
3
Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.治疗性纳米平台在 CNS 疾病治疗中的应用:挑战与可能。
Curr Pharm Des. 2022;28(33):2742-2757. doi: 10.2174/1381612828666220729104433.
4
Nanomedicine: A New Frontier in Alzheimer's Disease Drug Targeting.纳米医学:阿尔茨海默病药物靶向治疗的新前沿。
Cent Nerv Syst Agents Med Chem. 2025;25(1):3-19. doi: 10.2174/0118715249281331240325042642.
5
Delivery of Biologics Across the Blood-Brain Barrier with Molecular Trojan Horse Technology.利用分子木马技术将生物制剂递送到血脑屏障。
BioDrugs. 2017 Dec;31(6):503-519. doi: 10.1007/s40259-017-0248-z.
6
Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.中枢神经系统癌症的细胞和分子靶向药物递送:靶向策略的进展。
Curr Top Med Chem. 2020;20(30):2762-2776. doi: 10.2174/1568026620666200826122402.
7
Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood-brain barrier.影响血脑屏障受体介导的纳米药物递送的因素及潜在策略。
Expert Opin Drug Deliv. 2023 Jul-Dec;20(12):1713-1730. doi: 10.1080/17425247.2023.2245332. Epub 2023 Aug 10.
8
Blood-brain barrier drug delivery of IgG fusion proteins with a transferrin receptor monoclonal antibody.利用转铁蛋白受体单克隆抗体进行IgG融合蛋白的血脑屏障药物递送
Expert Opin Drug Deliv. 2015 Feb;12(2):207-22. doi: 10.1517/17425247.2014.952627. Epub 2014 Aug 20.
9
Therapeutic nanoplatforms and delivery strategies for neurological disorders.用于神经疾病的治疗性纳米平台及递送策略
Nano Converg. 2018 Nov 30;5(1):35. doi: 10.1186/s40580-018-0168-8.
10
Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.细胞外囊泡作为药物递送至中枢神经系统的载体。
J Neuroimmune Pharmacol. 2020 Sep;15(3):443-458. doi: 10.1007/s11481-019-09875-w. Epub 2019 Sep 4.

本文引用的文献

1
Drug Delivery Across the Blood-Brain Barrier: A New Strategy for the Treatment of Neurological Diseases.药物透过血脑屏障的递送:治疗神经疾病的新策略。
Pharmaceutics. 2024 Dec 19;16(12):1611. doi: 10.3390/pharmaceutics16121611.
2
Neuroprotective effects of baicalin and baicalein on the central nervous system and the underlying mechanisms.黄芩苷和黄芩素对中枢神经系统的神经保护作用及其潜在机制。
Heliyon. 2024 Dec 10;11(1):e41002. doi: 10.1016/j.heliyon.2024.e41002. eCollection 2025 Jan 15.
3
Cerebrospinal Fluid Flow.脑脊液流动
Annu Rev Fluid Mech. 2023;55:237-264. doi: 10.1146/annurev-fluid-120720-011638. Epub 2022 Sep 28.
4
Advancements in ultrasound-mediated drug delivery for central nervous system disorders.超声介导的中枢神经系统疾病药物递送的进展
Expert Opin Drug Deliv. 2025 Jan;22(1):15-30. doi: 10.1080/17425247.2024.2438188. Epub 2024 Dec 5.
5
Phytochemicals in Parkinson's Disease: a Pathway to Neuroprotection and Personalized Medicine.帕金森病中的植物化学物质:神经保护和个性化医疗之路
Cell Biochem Biophys. 2025 Jun;83(2):1427-1443. doi: 10.1007/s12013-024-01607-z. Epub 2024 Nov 13.
6
Target fishing and mechanistic insights of the natural anticancer drug candidate chlorogenic acid.天然抗癌候选药物绿原酸的靶向筛选及作用机制研究
Acta Pharm Sin B. 2024 Oct;14(10):4431-4442. doi: 10.1016/j.apsb.2024.07.005. Epub 2024 Jul 6.
7
Plant extracts as emerging modulators of neuroinflammation and immune receptors in Alzheimer's pathogenesis.植物提取物作为阿尔茨海默病发病机制中神经炎症和免疫受体的新兴调节剂。
Heliyon. 2024 Aug 10;10(16):e35943. doi: 10.1016/j.heliyon.2024.e35943. eCollection 2024 Aug 30.
8
Advances in Intrathecal Nanoparticle Delivery: Targeting the Blood-Cerebrospinal Fluid Barrier for Enhanced CNS Drug Delivery.鞘内纳米颗粒递送的进展:靶向血脑脊髓液屏障以增强中枢神经系统药物递送
Pharmaceuticals (Basel). 2024 Aug 15;17(8):1070. doi: 10.3390/ph17081070.
9
Delivery of natural products via polysaccharide-based nanocarriers for cancer therapy: A review on recent advances and future challenges.多糖基纳米载体用于癌症治疗的天然产物传递:近期进展与未来挑战综述。
Int J Biol Macromol. 2024 Oct;278(Pt 4):135072. doi: 10.1016/j.ijbiomac.2024.135072. Epub 2024 Aug 25.
10
Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction.血管内皮损伤相关疾病发病机制和治疗策略的新见解:聚焦于线粒体功能障碍。
Angiogenesis. 2024 Nov;27(4):623-639. doi: 10.1007/s10456-024-09938-4. Epub 2024 Jul 26.